ASPIRIN REDUCES LIVER FAT IN CLINICAL TRIAL OF THE MOST COMMON CAUSE OF CHRONIC LIVER DISEASE

  • Yujin Hoshida

Press/Media

Period22 Mar 2024

Media coverage

1

Media coverage

  • TitleASPIRIN REDUCES LIVER FAT IN CLINICAL TRIAL OF THE MOST COMMON CAUSE OF CHRONIC LIVER DISEASE
    Media name/outletStates News Service
    Country/TerritoryUnited States
    Date22/03/24
    PersonsYujin Hoshida